Literature DB >> 19040386

Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview.

Dwayne T Friesen1, Ravi Shanker, Marshall Crew, Daniel T Smithey, W J Curatolo, J A S Nightingale.   

Abstract

Spray-dried dispersions (SDDs) of low-solubility drugs have been prepared using the polymer hydroxypropyl methylcellulose acetate succinate (HPMCAS). For a variety of drug structures, these SDDs provide supersaturation in in vitro dissolution determinations and large bioavailability increases in vivo. In bile-salt/lecithin in vitro solutions, these SDDs provide amorphous drug/polymer colloids and an increased concentration of free drug and drug in micelles relative to crystalline or amorphous drug. As dry powders, the SDDs are a single amorphous phase in which the drug remains amorphous and dispersed and does not crystallize over storage times relevant for practical drug products. A melting temperature (Tm)/glass-transition temperature (Tg) (K/K) versus log P map for 139 compounds formulated as SDDs provides a perspective on an appropriate formulation strategy for low-solubility drugs with various physical properties.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19040386     DOI: 10.1021/mp8000793

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  64 in total

1.  Development of a Control Strategy for Benzene Impurity in HPMCAS-Stabilized Spray-Dried Dispersion Drug Products Using a Science-Based and Risk-Based Approach.

Authors:  Hongfei Yue; Sarah J Nicholson; Joel D Young; Daniel Hsieh; Rodney J Ketner; Robert G Hall; Jeremy Sackett; Elizabeth C Banks; John A Castoro; Michael E Randazzo
Journal:  Pharm Res       Date:  2015-02-28       Impact factor: 4.200

2.  Solution behavior of PVP-VA and HPMC-AS-based amorphous solid dispersions and their bioavailability implications.

Authors:  Feng Qian; Jennifer Wang; Ruiling Hartley; Jing Tao; Raja Haddadin; Neil Mathias; Munir Hussain
Journal:  Pharm Res       Date:  2012-10       Impact factor: 4.200

3.  Design of dry nanosuspension with highly spontaneous dispersible characteristics to develop solubilized formulation for poorly water-soluble drugs.

Authors:  Toshiyuki Niwa; Satoru Miura; Kazumi Danjo
Journal:  Pharm Res       Date:  2011-05-28       Impact factor: 4.200

4.  Using Environment-Sensitive Fluorescent Probes to Characterize Liquid-Liquid Phase Separation in Supersaturated Solutions of Poorly Water Soluble Compounds.

Authors:  Shweta A Raina; David E Alonzo; Geoff G Z Zhang; Yi Gao; Lynne S Taylor
Journal:  Pharm Res       Date:  2015-06-27       Impact factor: 4.200

5.  Analysis of a nanocrystalline polymer dispersion of ebselen using solid-state NMR, Raman microscopy, and powder X-ray diffraction.

Authors:  Frederick G Vogt; Glenn R Williams
Journal:  Pharm Res       Date:  2012-02-25       Impact factor: 4.200

6.  In vitro and in vivo evaluation of amorphous solid dispersions generated by different bench-scale processes, using griseofulvin as a model compound.

Authors:  Po-Chang Chiang; Yong Cui; Yingqing Ran; Joe Lubach; Kang-Jye Chou; Linda Bao; Wei Jia; Hank La; Jonathan Hau; Amy Sambrone; Ann Qin; Yuzhong Deng; Harvey Wong
Journal:  AAPS J       Date:  2013-03-02       Impact factor: 4.009

7.  Improved ziprasidone formulations with enhanced bioavailability in the fasted state and a reduced food effect.

Authors:  Avinash G Thombre; Scott M Herbig; Jeffrey A Alderman
Journal:  Pharm Res       Date:  2011-06-15       Impact factor: 4.200

8.  Dissolution enhancement of a drug exhibiting thermal and acidic decomposition characteristics by fusion processing: a comparative study of hot melt extrusion and KinetiSol dispersing.

Authors:  Justin R Hughey; James C DiNunzio; Ryan C Bennett; Chris Brough; Dave A Miller; Hua Ma; Robert O Williams; James W McGinity
Journal:  AAPS PharmSciTech       Date:  2010-05-05       Impact factor: 3.246

9.  Insights into atomic-level interaction between mefenamic acid and eudragit EPO in a supersaturated solution by high-resolution magic-angle spinning NMR spectroscopy.

Authors:  Kenjirou Higashi; Kazutoshi Yamamoto; Manoj Kumar Pandey; Kamal H Mroue; Kunikazu Moribe; Keiji Yamamoto; Ayyalusamy Ramamoorthy
Journal:  Mol Pharm       Date:  2013-12-09       Impact factor: 4.939

10.  Novel Gefitinib Formulation with Improved Oral Bioavailability in Treatment of A431 Skin Carcinoma.

Authors:  Chandraiah Godugu; Ravi Doddapaneni; Apurva R Patel; Rakesh Singh; Roger Mercer; Mandip Singh
Journal:  Pharm Res       Date:  2015-08-19       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.